김청수 MD., PhD

by 관리자 posted Nov 18, 2015
?

단축키

Prev이전 문서

Next다음 문서

ESC닫기

크게 작게 위로 아래로 댓글로 가기 인쇄
Extra Form
소속 서울아산병원
기관명 서울아산병원 비뇨기과
전공 비뇨기과학/ 비뇨기암
Extra Form
논문 Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer
Invest New Drugs (2017)

Downregulation of androgen receptors by NaAsO2 via inhibition of AKT-NF-kB and HSP90 in castration
resistant prostate cancer
Prostate (2017)

Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and
activation of NF-κB
Oncotarget (2016)

Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant
prostate cancer Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition
in castration-resistant prostate cancer
Prostate (2016)

Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse
-probability-of-treatment weighting
J Cancer Rees Clin Oncol (2015)

Combination Treatment of Renal Cell Carcinoma with Belinostat and 5-Fluorouracil:
A Role for Oxidative Stress-Induced DNA Damage and HSP90-Regulated Thymidine Synthase
Journal of Urology(2015)

Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease
J Cancer Res Clin Oncol. (2014)

A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-(XL)
Invest New drugs (2012)

Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy
BJU Int. (2012)

특허 유전자의 메틸화 여부 및 비율의 분석방법
대한민국 (2010)

Novel pyridopirimidine derivatives and use thereof
미국 (2014)

Substituted pyridinone compounds as a MEK inhibitors
미국 (2015)
기타

국가연구개발사업 참여

 

번호

과제명

주관부처

연구기간

(부터-까지)

역할

1

국가지정 항암 선도기술 개발지원 센터

보건복지부

2010.05.01-2015.03.31

참여

2

선도형 암 연구 사업단

보건복지부

2011.12.01-2016.11.30

참여

3

신기능 항암제 개발을 통한 혁신형 암 연구중심병원

보건복지부

2006.12.01-2011.11.30

책임

4

병원 주도 첨단 생명-정보-공학-임상융합연구

한국보건산업진흥원

2013.11.01-2019.10.31

책임

5

난치성 발기부전 치료를 위한 골수유래 중간엽줄기세포 치료제 허가용 비임상 연구

보건복지부

2012.12.26-2014.11.25

책임

 

임상자문

 

Articles

1